Measles, mumps and rubella vaccine - Kaketsuken

Drug Profile

Measles, mumps and rubella vaccine - Kaketsuken

Alternative Names: KM-248

Latest Information Update: 31 Dec 2015

Price : $50

At a glance

  • Originator Kaketsuken
  • Class Measles vaccines; Rubella vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preregistration Measles; Mumps; Rubella

Most Recent Events

  • 30 Dec 2015 Preregistration for Measles, Mumps and Rubella in Japan (IM, SC) prior to December 2015 (Kaketsuken pipeline, December 2015) (Kaketsuken pipeline, December 2015)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top